Cogent Biosciences Statistics
Total Valuation
COGT has a market cap or net worth of $5.07 billion. The enterprise value is $4.52 billion.
| Market Cap | 5.07B |
| Enterprise Value | 4.52B |
Important Dates
The last earnings date was Thursday, November 5, 2026, after market close.
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
COGT has 174.04 million shares outstanding. The number of shares has increased by 37.67% in one year.
| Current Share Class | 173.99M |
| Shares Outstanding | 174.04M |
| Shares Change (YoY) | +37.67% |
| Shares Change (QoQ) | +1.24% |
| Owned by Insiders (%) | 0.55% |
| Owned by Institutions (%) | 119.34% |
| Float | 173.03M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | 29.98 |
| PB Ratio | 11.23 |
| P/TBV Ratio | 11.23 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.99, with a Debt / Equity ratio of 0.47.
| Current Ratio | 10.99 |
| Quick Ratio | 10.82 |
| Debt / Equity | 0.47 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -85.23 |
Financial Efficiency
Return on equity (ROE) is -99.59% and return on invested capital (ROIC) is -47.05%.
| Return on Equity (ROE) | -99.59% |
| Return on Assets (ROA) | -42.02% |
| Return on Invested Capital (ROIC) | -47.05% |
| Return on Capital Employed (ROCE) | -55.72% |
| Weighted Average Cost of Capital (WACC) | 5.92% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.58M |
| Employee Count | 258 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -12.81% in the last 52 weeks. The beta is 0.34, so COGT's price volatility has been lower than the market average.
| Beta (5Y) | 0.34 |
| 52-Week Price Change | -12.81% |
| 50-Day Moving Average | 31.52 |
| 200-Day Moving Average | 35.35 |
| Relative Strength Index (RSI) | 42.58 |
| Average Volume (20 Days) | 2,185,778 |
Short Selling Information
The latest short interest is 19.66 million, so 11.30% of the outstanding shares have been sold short.
| Short Interest | 19.66M |
| Short Previous Month | 19.46M |
| Short % of Shares Out | 11.30% |
| Short % of Float | 11.36% |
| Short Ratio (days to cover) | 8.48 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -422.92M |
| Pretax Income | -407.68M |
| Net Income | -407.68M |
| EBITDA | -420.36M |
| EBIT | -422.92M |
| Earnings Per Share (EPS) | -$2.48 |
Balance Sheet
The company has $791.13 million in cash and $244.22 million in debt, with a net cash position of $546.91 million or $3.14 per share.
| Cash & Cash Equivalents | 791.13M |
| Total Debt | 244.22M |
| Net Cash | 546.91M |
| Net Cash Per Share | $3.14 |
| Equity (Book Value) | 516.26M |
| Book Value Per Share | 2.59 |
| Working Capital | 730.47M |
Cash Flow
In the last 12 months, operating cash flow was -$324.05 million and capital expenditures -$1.74 million, giving a free cash flow of -$325.78 million.
| Operating Cash Flow | -324.05M |
| Capital Expenditures | -1.74M |
| Depreciation & Amortization | 2.57M |
| Net Borrowing | 168.47M |
| Free Cash Flow | -325.78M |
| FCF Per Share | -$1.87 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
COGT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -37.67% |
| Shareholder Yield | -37.67% |
| Earnings Yield | -8.52% |
| FCF Yield | -6.42% |
Analyst Forecast
The average price target for COGT is $55.82, which is 91.56% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $55.82 |
| Price Target Difference | 91.56% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 12 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
The last stock split was on November 9, 2020. It was a reverse split with a ratio of 1:4.
| Last Split Date | Nov 9, 2020 |
| Split Type | Reverse |
| Split Ratio | 1:4 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |